文章摘要

文章信息/Info

Title:: Effect of combination of ezetimibe and atorvastatin on serum lipid in elderly patients with coronary artery disease

作者:: 杨栋¹; 2; 苏慧¹; (1.第四军医大学西京医院老年病科，陕西西安 710032；2.兰州军区临潼疗养院第二疗养区，陕西西安 710600)

Author(s):: YANG Dong¹; 2; SU Hui¹; (1.Second Section, Lintong Sanatorium, Lanzhou Military Area Command, Xi’an 710600, Shaanxi, China; 2.Department of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)

关键词:: 依折麦布; 阿托伐他汀; 老年; 冠状动脉疾病; 低密度脂蛋白胆固醇

Keywords:: ezetimibe; atorvastatin; the elderly; coronary artery disease; LDLC

分类号:: R541.4

DOI:: -

文献标识码:: A

摘要:: 目的:观察联合应用依折麦布和阿托伐他汀对老年冠心病患者血脂水平的影响。方法：选择常规应用阿托伐他汀钙片20 mg/d但血脂仍未达标的，符合入选标准的老年冠心病患者176例，随机分成两组，对照组为高剂量他汀组：阿托伐他汀钙片40 mg/d；试药组为联合用药组：依折麦布10 mg/d联合阿托伐他汀钙片20 mg/d；比较两组治疗前后血总胆固醇（TC）、低密度脂蛋白胆固醇（LDLC）水平变化。结果：经12周治疗后，两组TC、LDLC与治疗前比较均有显著降低（均P<005）；与高剂量他汀组相比，联合降脂组治疗效果更显著（P<005），TC、LDLC下降更明显（P<005）；而肝损害及肌溶解等副作用的发生率却无明显增加。结论：与高剂量阿托伐他汀相比，依折麦布联合阿托伐他汀具有更好的降低LDLC效果，显著提高冠心病患者的血脂达标率，且具有良好的安全性和药物耐受性。

Abstract:: AIM:To observe the effect of combination of ezetimibe and atorvastatin on the serum lipid of elderly patients with coronary heart disease. METHODS: One hundred and seventysix elderly patients with coronary artery disease whose serum lipid level did not meet normal criteria after taking atorvastatin 20 mg/d were assigned randomly to two groups. Patients in highdose atorvastatin group were treated with atorvastatin 40 mg/d and patients in combination group were treated with ezetimibe 10 mg/d and lowdose atorvastatin 20 mg/d. The changes of serum lipid and side effects were compared between the two groups. RESULTS: Total cholesterol (TC) and low density lipoproteincholesterol (LDLC) decreased significantly in both groups after the 12week therapy (P<005). Compared with those in highdose atorvastatin group, serum TC and LDLC decreased markedly (P<005) and serum lipid control rate was much higher in combination group. However, the rate of hepatic damage in combination group was much lower than that in highdose atorvastatin group. CONCLUSION: Compared with highdose atorvastatin, combination of ezetimibe and lowdose atorvastatin, safe and welltolerated, can more significantly decrease TC and LDLC and improve serum lipid control rate.

参考文献/References

[1]Law MR,Wald NJ,Rudnicka AR.Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke:systematic review and metaanalysis[J].BMJ,2003,326(7404):1423.
[2]赵水平.《中国成人血脂异常防治指南》要点及解读[J]. 实用医院临床杂志,2008,5(3):3-6.
[3]潘小进,崔爱红,丁国华,等.高血压及相关危险因素对动脉弹性的影响[J].中国老年学杂志,2010,30(19):2739-2741.
[4]中国临床血脂制达标行动专家组.提高临床血脂控制达标率的专家建议[J].中华心血管病杂志,2010,38(4):294-298.
[5]Miura S,Saku K.Beneficial effects of ezetimibebased therapy in patients with dyslipidemia[J].J Cardiol,2008,52(1):1-6.
[6]Maki-Petaja KM,Booth AD,Hall FC,et al.Ezetimibeand simvastatin reduce inflammation, disease activity,and aorti cstiffness and improve endothelial function in rheumatoid arthritis[J].J Am Coll Cardiol,2007,50(9):852-858.

我们的网站为什么显示成这样？

依折麦布联合阿托伐他汀治疗老年冠心病患者的降脂疗效

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics